
Black and Hispanic patients are less likely to be given antiviral drugs such as Paxlovid to help battle a bout of COVID-19 than white patients are, a new government report shows. In a study of more than 700,000 patients with COVID-19, researchers from the U.S. Centers for Disease Control and Prevention found that Black patients… read on > read on >